𝔖 Bobbio Scriptorium
✦   LIBER   ✦

p53, vessel count, and vascular endothelial growth factor expression in human colon cancer

✍ Scribed by Yutaka Takahashi; Corazon D. Bucana; Karen R. Cleary; Lee M. Ellis


Publisher
John Wiley and Sons
Year
1998
Tongue
French
Weight
216 KB
Volume
79
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


We previously demonstrated an association between vascular endothelial growth factor (VEGF), vessel counts and metastasis in human colon cancer specimens. Mutant p53 has been implicated in the regulation of angiogenesis. Immunohistochemical detection of p53 protein has been associated with p53 gene mutations. We sought to determine a correlation between p53 protein detection (i.e., mutant p53), VEGF expression and vessel counts in human colon cancer. Surgical specimens from 93 patients with colon cancer were stained immuno-histochemically for p53, VEGF and factor VIII. Vessel counts were greater in metastatic tumors than in nonmetastatic tumors and adenomas, and greater in nonmetastatic tumors than in adenomas. Vessel counts were highest in tumors with the highest VEGF expression. Vessel counts and VEGF expression were greater in p53-positive tumors than in p53-negative tumors. p53 expression correlated with both VEGF expression and vessel count. The association of p53 expression with VEGF and vessel count suggests that the poor prognosis associated with p53 mutations may be due, in part, to the role of mutant p53 in promoting angiogenesis.


πŸ“œ SIMILAR VOLUMES


Vascular endothelial growth factor (vasc
✍ Efstathios Papavassiliou; Nitin Gogate; Martin Proescholdt; John D. Heiss; Stuar πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 297 KB

We investigated the expression of vascular endothelial growth factor (VEGF)/vascular permeability factor (VPF) in stab and freeze brain injury models in rats. Immunohistochemical staining with anti-VEGF antibodies demonstrated an increase in VEGF-positive cells in and around both lesions. Morphologi

Expression of vascular endothelial growt
✍ Langer, Ingrid; Vertongen, Pascale; Perret, Jason; Fontaine, Jeanine; Atassi, Gh πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 406 KB πŸ‘ 1 views

Background. Vascular endothelial growth factor (VEGF) is a specific endothelial cell mitogen that stimulates angiogenesis and plays a crucial role in tumor growth. The aim of the present study was to evaluate the expression of VEGF and of its two high-affinity tyrosine kinase receptors (KDR and Flt-

Concomitant over-expression of vascular
✍ Jun Itakura; Toshiyuki Ishiwata; Ben Shen; Marko Kornmann; Murray Korc πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 French βš– 443 KB πŸ‘ 1 views

Vascular endothelial growth factor (VEGF) is a potent angiogenic polypeptide that activates 2 distinct high-affinity tyrosine kinase receptors, flk-1/KDR and flt-1. In the present study, we characterized the expression of VEGF and its receptors flk-1/KDR and flt-1 in the normal human pancreas and in

p53 and vascular-endothelial-growth-fact
✍ Barbro Linderholm; Birgitta Lindh; BjΓΆrn Tavelin; Kjell Grankvist; Roger Henriks πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 French βš– 169 KB

The angiogenic factor vascular endothelial growth factor (VEGF) predicts outcome in primary breast carcinoma. Alteration of the p53 gene causes down-regulation of the expression of thrombospondin-1, a natural inhibitor of angiogenesis. This study was conducted to investigate the association between